BPC-157 promotes angiogenesis and tissue repair, which could theoretically affect surgical bleeding, though no specific studies address pre-operative cessation. Conservative approach suggests stopping 1-2 weeks before elective surgery and consulting with the surgical team. Post-operative use may benefit healing once acute bleeding risk has passed.
BPC-157 vascular effects